Histidine-tryptophan-ketoglutarate and university of wisconsin solution demonstrate equal effectiveness in the preservation of human pancreata intended for islet isolation: A large-scale, single-center experience

Cell Transplantation

Volumn 22, Issue 7, 2013, Pages 1113-1121

  Paushter, Daniel H ^a   Qi, Meirigeng ^a   Danielson, Kirstie K ^a   Harvat, Tricia A ^a   Kinzer, Katie ^a   Barbaro, Barbara ^a   Patel, Sonny ^a   Hassan, Sarah Z ^a   Oberholzer, Jose ^a   Wang, Yong ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cellular edema; Histidine tryptophan ketoglutarate (HTK); Human pancreas; Islet isolation; Islet transplantation; Organ preservation; University of wisconsin (UW)

Indexed keywords

HEMOGLOBIN A1C; HTK SOLUTION; INSULIN; UNIVERSITY OF WISCONSIN SOLUTION;

ARTICLE; CELL ISOLATION; CELL LOSS; CELL VIABILITY; COLD ISCHEMIA; HUMAN; HUMAN CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PURIFICATION; RETROSPECTIVE STUDY; TISSUE PRESERVATION;

ADULT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HISTIDINE; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KETOGLUTARIC ACIDS; MALE; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PANCREAS; TRANSPLANTATION, HOMOLOGOUS; TRYPTOPHAN;

EID: 84879560134     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657332     Document Type: Article

References (31)

1. Goggins, W. C.; Milgrom, M. L.; Fridell, J. A. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant. Proc. 37:3523-3526; 2005.
2. Barbaro, B.; Kuechle, J.; Salehi, P.; Rodriguez, L.; Qi, M.; Gangemi, A.; Benedetti, E.; Oberholzer, J. Increased albumin concentration reduces apoptosis and improves functionality of human islets. Artif. Cells Blood Substit. Immobil. Biotechnol. 36:74-81; 2008.
3. Barbaro, B.; Salehi, P.; Wang, Y.; Qi, M.; Gangemi, A.; Kuechle, J.; Hansen, M. A.; Romagnoli, T.; Avila, J.; Benedetti, E.; Mage, R.; Oberholzer, J. Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation 84:1200-1203; 2007.
4. Becker, T.; Ringe, B.; Nyibata, M.; Meyer zu Vilsendorf, A.; Schrem, H.; Luck, R.; Neipp, M.; Klempnauer, J.; Bektas, H. Pancreas transplantation with histidine-tryptophanketoglutarate (HTK) solution and University of Wisconsin (UW) solution: Is there a difference? JOP 8:304-311; 2007.
5. Belzer, F. O.; D'Alessandro, A. M.; Hoffmann, R. M.; Knechtle, S. J.; Reed, A.; Pirsch, J. D.; Kalayoglu, M.; Sollinger, H. W. The use of UW solution in clinical transplantation. A 4-year experience. Ann. Surg. 215:579-583; 1992.
6. Belzer, F. O.; Ploeg, R. J.; Knechtle, S. J.; D'Alessandro, A. M.; Pirsch, J. D.; Kalayoglu, M. M.; Sollinger, H. W. Clinical pancreas preservation and transplantation. Transplant. Proc. 26:550-551; 1994.
7. Brandhorst, H.; Hering, B. J.; Brandhorst, D.; Hiller, W. F.; Gubernatis, G.; Federlin, K.; Bretzel, R. G. Comparison of histidine-tryptophane-ketoglutarate (HTK) and University of Wisconsin (UW) solution for pancreas perfusion prior to islet isolation, culture and transplantation. Transplant. Proc. 27:3175-3176; 1995.
8. Bretschneider, H. J. Myocardial protection. Thorac. Cardiovasc. Surg. 28:295-302; 1980.
9. Chadwick, D. R.; Robertson, G. S.; Contractor, H. H.; Rose, S.; Johnson, P. R.; James, R. F.; Bell, P. R.; London, N. J. Storage of pancreatic digest before islet purification. The influence of colloids and the sodium to potassium ratio in University of Wisconsin-based preservation solutions. Transplantation 58:99-104; 1994.
10. Englesbe, M. J.; Moyer, A.; Kim, D. Y.; Granger, D. K.; Pietroski, R.; Yoshida, A.; Arenas, J. D.; Oh, H.; Pelletier, S. J.; Campbell, Jr., D. A.; Punch, J. D.; Magee, J. C.; Gruber, S. A.; Sung, R. S. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study. Transplantation 82:136-139; 2006.
11. Fridell, J. A.; Agarwal, A.; Milgrom, M. L.; Goggins, W. C.; Murdock, P.; Pescovitz, M. D. Comparison of histidinetryptophan- ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 77:1304-1306; 2004.
12. Fridell, J. A.; Mangus, R. S.; Powelson, J. A. Histidinetryptophan- ketoglutarate for pancreas allograft preservation: The Indiana University experience. Am. J. Transplant. 10:1284-1289; 2010.
13. Gangemi, A.; Salehi, P.; Hatipoglu, B.; Martellotto, J.; Barbaro, B.; Kuechle, J. B.; Qi, M.; Wang, Y.; Pallan, P.; Owens, C.; Bui, J.; West, D.; Kaplan, B.; Benedetti, E.; Oberholzer, J. Islet transplantation for brittle type 1 diabetes: The UIC protocol. Am. J. Transplant. 8:1250-1261; 2008.
14. Hering, B. J.; Matsumoto, I.; Sawada, T.; Nakano, M.; Sakai, T.; Kandaswamy, R.; Sutherland, D. E. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 74:1813-1816; 2002.
15. Hubert, T.; Gmyr, V.; Arnalsteen, L.; Jany, T.; Triponez, F.; Caiazzo, R.; Vandewalle, B.; Vantyghem, M. C.; Kerr- Conte, J.; Pattou, F. Influence of preservation solution on human islet isolation outcome. Transplantation 83:270-276; 2007.
16. Iwanaga, Y.; Sutherland, D. E.; Harmon, J. V.; Papas, K. K. Pancreas preservation for pancreas and islet transplantation. Curr. Opin. Organ Transplant. 13:135-141; 2008.
17. Ko, J. S.; Kim, G. S.; Gwak, M. S.; Yang, M.; Kim, H. K.; Shin, B. S.; Kim, J. K.; Lee, S. K. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant. Proc. 40:3308-3310; 2008.
18. Lakey, J. R.; Tsujimura, T.; Shapiro, A. M.; Kuroda, Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 74:1809-1811; 2002.
19. London, N. J.; Bell, P. R. Pancreas and islet transplantation. Br. J. Surg. 79:6-7; 1992.
20. Mangus, R. S.; Tector, A. J.; Agarwal, A.; Vianna, R.; Murdock, P.; Fridell, J. A. Comparison of histidinetryptophan- ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl. 12:226-230; 2006.
21. Ricordi, C.; Gray, D. W.; Hering, B. J.; Kaufman, D. B.; Warnock, G. L.; Kneteman, N. M.; Lake, S. P.; London, N. J.; Socci, C.; Alejandro, R.; Zeng, Y.; Scharp, D. W.; Viviani, G.; Falqui, L.; Tzakis, A.; Bretzel, R. G.; Federlin, K.; Pozza, G.; James, R. F. L.; Rajotte, R. V.; Di Carlo, V.; Morris, P. J.; Sutherland, D. E. R.; Starzl, T. E.; Mintz, D. H.; Lacy, P. E. Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27(3):185-195; 1990.
22. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37:413-420; 1988.
23. Salehi, P.; Hansen, M. A.; Avila, J. G.; Barbaro, B.; Gangemi, A.; Romagnoli, T.; Wang, Y.; Qi, M.; Murdock, P.; Benedetti, E.; Oberholzer, J. Human islet isolation outcomes from pancreata preserved with histidine-tryptophan ketoglutarate versus University of Wisconsin solution. Transplantation 82:983-985; 2006.
24. Schneeberger, S.; Biebl, M.; Steurer, W.; Hesse, U. J.; Troisi, R.; Langrehr, J. M.; Schareck, W.; Mark, W.; Margreiter, R.; Konigsrainer, A. A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation. Transpl. Int. 22:217-224; 2009.
25. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
26. Stewart, Z. A.; Cameron, A. M.; Singer, A. L.; Dagher, N. N.; Montgomery, R. A.; Segev, D. L. Histidine-tryptophanketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am. J. Transplant. 9:217-221; 2009.
27. Stewart, Z. A.; Cameron, A. M.; Singer, A. L.; Montgomery, R. A.; Segev, D. L. Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am. J. Transplant. 9:286-293; 2009.
28. Stewart, Z. A.; Lonze, B. E.; Warren, D. S.; Dagher, N. N.; Singer, A. L.; Montgomery, R. A.; Segev, D. L. Histidinetryptophan- ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants. Am. J. Transplant. 9:1048-1054; 2009.
29. Testa, G.; Malago, M.; Nadalin, S.; Treptow, B.; Paul, A.; Frilling, A.; Broelsch, C. E. Histidine-tryptophanketoglutarate versus University of Wisconsin solution in living donor liver transplantation: Results of a prospective study. Liver Transpl. 9:822-826; 2003.
30. Wojtusciszyn, A.; Bosco, D.; Morel, P.; Baertschiger, R.; Armanet, M.; Kempf, M. C.; Badet, L.; Toso, C.; Berney, T. A comparison of cold storage solutions for pancreas preservation prior to islet isolation. Transplant. Proc. 37:3396-3397; 2005.
31. Yang, H.; Acker, J.; Chen, A.; McGann, L. In situ assessment of cell viability. Cell Transplant. 7:443-451; 1998.